TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and Eric Hughes ...
1 Day TEVA 0.23% DJIA 0.97% S&P 500 0.35% Health Care/Life Sciences 0.14% ...
After hours: November 22 at 7:58 p.m. EST ...
In its second pipeline-boosting deal in two days, Sanofi has pledged €469 million (around $490 million) upfront for rights to an anti-TL1A therapy being developed by Teva for inflammatory bowel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback